コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 acids in a sequence known as a hemITAM (hemi-immunoreceptor tyrosine-based activation motif).
2 e Fc receptor gamma chain, which contains an immunoreceptor tyrosine-based activation motif.
3 rn-helix configuration characteristic of the immunoreceptor tyrosine-based activation motif.
4 n tyrosine and threonine residues within the immunoreceptor tyrosine-based activation motif.
5 e downstream of receptors that signal via an immunoreceptor tyrosine-based activation motif.
6 osphorylated following the binding of Syk to immunoreceptor tyrosine-based activation motif.
7 e PECAM-1 cytoplasmic domain sequence to the immunoreceptor tyrosine-based activation motif.
8 platelet activation that both signal via an immunoreceptor tyrosine-based activation motif.
9 ytotoxicity via an atypical cytoplasmic hemi-immunoreceptor tyrosine-based activation motif.
10 am of the Fc receptor gamma-chain-associated immunoreceptor tyrosine-based activation motif.
11 vation by other receptor complexes that lack immunoreceptor tyrosine-based activation motifs.
12 ciated protein of 70 kDa kinase to the TCR's immunoreceptor tyrosine-based activation motifs.
13 th the Fc receptor gamma chain that contains immunoreceptor tyrosine-based activation motifs.
14 integrin Mac-1 and utilize signals involving immunoreceptor tyrosine-based activation motifs.
15 tment of extrinsic kinases to phosphorylated immunoreceptor tyrosine-based activation motifs.
16 e assay, although it has little affinity for immunoreceptor tyrosine-based activation motifs.
17 rresponding to the CD3epsilon or the TCRzeta immunoreceptor tyrosine-based activation motifs.
18 sphorylated tyrosines within the FcepsilonRI immunoreceptor tyrosine-based activation motifs.
20 ich associate with adaptor molecules bearing immunoreceptor tyrosine-based activation motifs and indu
21 Syk had decreased binding to phosphorylated immunoreceptor tyrosine-based activation motifs and redu
22 ly by two amino acid sequence motifs, ITAMs (immunoreceptor tyrosine-based activation motifs) and ITI
23 P2A occurs at the two tyrosines of the LMP2A immunoreceptor tyrosine-based activation motif, and it i
24 maRIIA, whose cytosolic sequence contains an immunoreceptor tyrosine-based activation motif, and the
25 the SH2 domain of Csk, as well as the LMP2A immunoreceptor tyrosine-based activation motif, are impo
26 all-trans-retinoic acid treatment or active immunoreceptor tyrosine-based activation motif-bearing (
27 in receptors, such as Ly49H, associated with immunoreceptor tyrosine-based activation motif-bearing a
28 ytokine receptor-mediated responses, whereas immunoreceptor tyrosine-based activation motif containin
29 ted through noncovalent association with the immunoreceptor tyrosine-based activation motif-containin
30 nitiate signaling cascades through DAP10- or immunoreceptor tyrosine-based activation motif-containin
31 )-GPVI, even though the association with the immunoreceptor tyrosine-based activation motif-containin
32 SLP-76 and BLNK link immunoreceptor tyrosine-based activation motif-containin
33 ion of the Syk/ZAP70 tyrosine kinases by the immunoreceptor tyrosine-based activation motif-containin
34 Ly-49D activation is mediated by the immunoreceptor tyrosine-based activation motif-containin
35 a R-mediated signal transduction by engaging immunoreceptor tyrosine-based activation motif-containin
36 ependent signal transduction mediated by the immunoreceptor tyrosine-based activation motif-containin
37 The hemi-immunoreceptor tyrosine-based activation motif-containin
38 naling as well as costimulatory signals from immunoreceptor tyrosine-based activation motif-containin
39 s, including the integrin alphaIIbbeta3, the immunoreceptor tyrosine-based activation motif-containin
40 y receptors that have 1 or more copies of an immunoreceptor tyrosine-based activation motif, defined
41 prevent inflammatory bleeding through (hem) immunoreceptor tyrosine-based activation motif-dependent
42 ins interacting with a doubly phosphorylated immunoreceptor tyrosine-based activation motif (dp-ITAM)
43 latory signal that prevents expression of an immunoreceptor tyrosine-based activation motif-free IgE
44 cells expressing the mutated FcepsilonRIbeta immunoreceptor tyrosine-based activation motifs FYY, YYF
45 nd to transduce a positive signal through an immunoreceptor tyrosine-based activation motif grafted o
46 (NFATc1, RANK, costimulatory receptors, and immunoreceptor tyrosine-based activation motif-harboring
47 it is the only one to signal through a hemi-immunoreceptor tyrosine-based activation motif (hemITAM)
48 2 mediates platelet activation through a hem-immunoreceptor tyrosine-based activation motif (hemITAM)
49 ic sequence motif of NKp65 resembling a hemi-immunoreceptor tyrosine-based activation motif (hemITAM)
50 single cytoplasmic YxxL motif known as a hem immunoreceptor tyrosine-based activation motif (hemITAM)
51 tetherin cytoplasmic tail resembles the hemi-immunoreceptor tyrosine-based activation motifs (hemITAM
53 nRI alpha-chains induces cell activation via immunoreceptor tyrosine-based activation motifs in assoc
54 ains appear to have significant affinity for immunoreceptor tyrosine-based activation motifs in vitro
55 through tyrosine phosphorylation of an ITAM (immunoreceptor tyrosine-based activation motif) in the F
57 This is a likely requirement for immunoreceptor tyrosine-based activation motifs involved
58 Its zeta-subunit contains multiple cytosolic immunoreceptor tyrosine-based activation motifs involved
59 d cytoplasmic domain, inclusive of the ITAM (immunoreceptor tyrosine-based activation motif) involved
60 have also determined that an intact FcgammaR immunoreceptor tyrosine-based activation motif is requir
61 induced IL-4 production was dependent on the immunoreceptor tyrosine-based activation motif (ITAM) ad
63 release in response to stimulation of (hem) immunoreceptor tyrosine-based activation motif (ITAM) an
64 osphorylated DAP12, an adaptor containing an immunoreceptor tyrosine-based activation motif (ITAM) an
65 ansmembrane glycoprotein having a functional immunoreceptor tyrosine-based activation motif (ITAM) ca
66 in kinase C, all downstream mediators of the immunoreceptor tyrosine-based activation motif (ITAM) ca
67 s of Ig alpha or Ig beta have shown that the immunoreceptor tyrosine-based activation motif (ITAM) fo
70 (ER) trafficking and a functional signaling immunoreceptor tyrosine-based activation motif (ITAM) in
71 ma-associated herpesvirus (KSHV) contains an immunoreceptor tyrosine-based activation motif (ITAM) in
73 s in Syk mediate binding to a phosphorylated immunoreceptor tyrosine-based activation motif (ITAM) in
74 a disulphide-bonded homodimer containing an immunoreceptor tyrosine-based activation motif (ITAM) in
75 direct evidence of an essential role for the immunoreceptor tyrosine-based activation motif (ITAM) in
76 orresponding to the sequence of the atypical immunoreceptor tyrosine-based activation motif (ITAM) in
77 ough activating Fcgamma receptors bearing an immunoreceptor tyrosine-based activation motif (ITAM) in
78 lian Syk and Zap-70, binds Draper through an immunoreceptor tyrosine-based activation motif (ITAM) in
79 kinase activity and consequent to biased BCR immunoreceptor tyrosine-based activation motif (ITAM) mo
80 rosine to phenylalanine substitutions in the immunoreceptor tyrosine-based activation motif (ITAM) of
81 osphorylated synthetic peptides based on the immunoreceptor tyrosine-based activation motif (ITAM) of
82 et glycoprotein receptors that signal via an immunoreceptor tyrosine-based activation motif (ITAM) or
83 duces receptor oligomerization, Igalpha/beta immunoreceptor tyrosine-based activation motif (ITAM) ph
84 he B cell antigen receptor (BCR) via the non-immunoreceptor tyrosine-based activation motif (ITAM) ph
86 y to associate with c-Src is mediated by the immunoreceptor tyrosine-based activation motif (ITAM) pr
87 tion, and that this phenotype depended on an immunoreceptor tyrosine-based activation motif (ITAM) pr
88 Previously, we had shown that activation of immunoreceptor tyrosine-based activation motif (ITAM) pr
89 plays a prominent role in the regulation of immunoreceptor tyrosine-based activation motif (ITAM) si
90 , Cbl, Shc, and Grb2 have been implicated in immunoreceptor tyrosine-based activation motif (ITAM) si
91 rment of differentiation required the PY and immunoreceptor tyrosine-based activation motif (ITAM) si
92 ine kinase family plays an essential role in immunoreceptor tyrosine-based activation motif (ITAM) si
94 DAP12 is a signaling adaptor containing an immunoreceptor tyrosine-based activation motif (ITAM) th
96 HV) K1 gene encodes a polypeptide bearing an immunoreceptor tyrosine-based activation motif (ITAM) th
97 eptides, and stable transfectants expressing immunoreceptor tyrosine-based activation motif (ITAM) ty
98 alpha cytoplasmic tails we show that the non-immunoreceptor tyrosine-based activation motif (ITAM) ty
99 orylated specifically at two of the six zeta immunoreceptor tyrosine-based activation motif (ITAM) ty
100 (WT) gamma chain or gamma chain in which the immunoreceptor tyrosine-based activation motif (ITAM) wa
101 to the fact that Fc gamma contains a single immunoreceptor tyrosine-based activation motif (ITAM) wh
102 osphorylated on two tyrosine residues of the immunoreceptor tyrosine-based activation motif (ITAM), l
103 domains containing one or more copies of an immunoreceptor tyrosine-based activation motif (ITAM), t
104 d by 2 receptors that signal through an (hem)immunoreceptor tyrosine-based activation motif (ITAM), t
105 on and its surrounding sequence resemble the immunoreceptor tyrosine-based activation motif (ITAM), w
106 ng pathway that relies on a highly conserved immunoreceptor tyrosine-based activation motif (ITAM), w
108 f a chimeric receptor containing CD8 and the immunoreceptor tyrosine-based activation motif (ITAM)-be
111 signaling mediators activated downstream of immunoreceptor tyrosine-based activation motif (ITAM)-co
113 esignated as calcineurin/NFAT-activating and immunoreceptor tyrosine-based activation motif (ITAM)-co
114 Vav2, in the activation of platelets by the immunoreceptor tyrosine-based activation motif (ITAM)-co
118 rs have been shown to inhibit signaling from immunoreceptor tyrosine-based activation motif (ITAM)-co
120 that a signaling pathway mediated by the DC immunoreceptor tyrosine-based activation motif (ITAM)-co
121 target cell interactions or ligation of the immunoreceptor tyrosine-based activation motif (ITAM)-co
122 NK cell-activating receptors signal through immunoreceptor tyrosine-based activation motif (ITAM)-co
124 te that a signaling pathway initiated by the immunoreceptor tyrosine-based activation motif (ITAM)-co
125 er, little is known about how CD45 regulates immunoreceptor tyrosine-based activation motif (ITAM)-de
126 mmatory disease, which signal through a (hem)immunoreceptor tyrosine-based activation motif (ITAM)-de
127 ike protein 5 (FCRL5) on B cells has both an immunoreceptor tyrosine-based activation motif (ITAM)-li
128 brane molecules, FcRH1 is unique in having 2 immunoreceptor tyrosine-based activation motif (ITAM)-li
129 a transmembrane protein bearing a functional immunoreceptor tyrosine-based activation motif (ITAM)-li
130 receptors inhibit cellular responsiveness to immunoreceptor tyrosine-based activation motif (ITAM)-li
131 show that although CD45 is necessary for all immunoreceptor tyrosine-based activation motif (ITAM)-sp
132 d a previously unrecognized carboxy-terminal immunoreceptor tyrosine-based activation motif (ITAM).
133 nsmembrane glycoprotein bearing a functional immunoreceptor tyrosine-based activation motif (ITAM).
134 protein of 178 amino acids that contains an immunoreceptor tyrosine-based activation motif (ITAM).
135 ar activation events through its cytoplasmic immunoreceptor tyrosine-based activation motif (ITAM).
136 ies of a semiconserved functional motif, the immunoreceptor tyrosine-based activation motif (ITAM).
137 aining a Src homology 3 domain as well as an immunoreceptor tyrosine-based activation motif (ITAM).
138 th mouse DAP12, a molecule that possesses an immunoreceptor tyrosine-based activation motif (ITAM).
139 gnals via a cytoplasmic sequence, termed the immunoreceptor tyrosine-based activation motif (ITAM).
140 ssociated proteins share a common motif, the immunoreceptor tyrosine-based activation motif (ITAM).
141 pproximately 18-amino-acid domain called the immunoreceptor tyrosine-based activation motif (ITAM).
142 nRI) contain a consensus sequence termed the immunoreceptor tyrosine-based activation motif (ITAM).
143 signal transduction that are mediated by the immunoreceptor tyrosine-based activation motif (ITAM).
144 tyrosine residues arranged in a noncanonical immunoreceptor tyrosine-based activation motif (ITAM).
145 nd the Fc receptor gamma-chain, which has an immunoreceptor tyrosine-based activation motif (ITAM).
146 motes engulfment of axonal debris through an immunoreceptor tyrosine-based activation motif (ITAM).
147 izes two tandem YXXL repeats presented as an immunoreceptor tyrosine-based activation motif (ITAM).
148 gnaling, including CD79a, a protein with the immunoreceptor tyrosine-based activation motif (ITAM).
149 C: central supramolecular activation cluster Immunoreceptor tyrosine-based activation motif (ITAM): a
150 d in this process and include molecules with immunoreceptor tyrosine-based activation motifs (ITAM) a
151 wn tyrosine phosphorylation sites within the immunoreceptor tyrosine-based activation motifs (ITAM) o
153 complex contains 10 copies of a di-tyrosine Immunoreceptor-Tyrosine-based-Activation-Motif (ITAM) th
154 intracytoplasmic tails (FcgammaRIIa with an immunoreceptor tyrosine-based activation motif [ITAM] an
155 in) complex or a functional FcR gamma-chain (immunoreceptor tyrosine-based activation motif [ITAM] po
156 is a model for the study of immunoreceptor (immunoreceptor tyrosine-based activation motif [ITAM]) s
157 responses depends on the phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs)
159 on signaling paradigm whereby phosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs)
160 ignaling processes are controlled by the ten immunoreceptor tyrosine-based activation motifs (ITAMs)
161 tigated the roles of the Src kinase Lyn, the immunoreceptor tyrosine-based activation motifs (ITAMs)
162 were designed based on the sequences of the immunoreceptor tyrosine-based activation motifs (ITAMs)
164 ave identified key signaling elements termed immunoreceptor tyrosine-based activation motifs (ITAMs)
165 l receptor (TCR) zeta subunit contains three immunoreceptor tyrosine-based activation motifs (ITAMs)
166 contains multiple signaling motifs, known as immunoreceptor tyrosine-based activation motifs (ITAMs)
167 tein tyrosine kinases and phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs)
168 the receptor within conserved motifs termed Immunoreceptor Tyrosine-based Activation Motifs (ITAMs)
169 d out mutagenesis to address the role of the immunoreceptor tyrosine-based activation motifs (ITAMs)
170 he TCR by binding to tyrosine-phosphorylated immunoreceptor tyrosine-based activation motifs (ITAMs)
173 icate balance between receptors that contain immunoreceptor tyrosine-based activation motifs (ITAMs)
174 with each receptor independently through the immunoreceptor tyrosine-based activation motifs (ITAMs)
175 nt function of receptors that signal through immunoreceptor tyrosine-based activation motifs (ITAMs)
176 ion to the tyrosines of the Igalpha and beta immunoreceptor tyrosine-based activation motifs (ITAMs),
177 a set of 10 intracytoplasmic motifs, termed immunoreceptor tyrosine-based activation motifs (ITAMs),
178 l transduction processes are mediated by the immunoreceptor tyrosine-based activation motifs (ITAMs),
180 ceptor signaling through adaptors containing immunoreceptor tyrosine-based activation motifs (ITAMs),
181 elopment can proceed with as few as 4/10 CD3 immunoreceptor tyrosine-based activation motifs (ITAMs),
182 0 sites that are distributed on 10 conserved immunoreceptor tyrosine-based activation motifs (ITAMs).
183 a tandem SH2 unit responsible for binding to immunoreceptor tyrosine-based activation motifs (ITAMs).
184 R through interaction with RhoH noncanonical immunoreceptor tyrosine-based activation motifs (ITAMs).
185 asmic domain of K1 resembles the sequence of immunoreceptor tyrosine-based activation motifs (ITAMs).
186 the tyrosines modified are in the so-called immunoreceptor tyrosine-based activation motifs (ITAMs).
187 orylated by the phosphatase CD45 on multiple immunoreceptor tyrosine-based activation motifs (ITAMs).
188 complex is unique in having ten cytoplasmic immunoreceptor tyrosine-based activation motifs (ITAMs).
189 e regulated by receptors that signal through immunoreceptor tyrosine-based activation motifs (ITAMs).
190 equirements for a large number of functional immunoreceptor tyrosine-based activation motifs (ITAMs;
191 express K1 and a K1 mutant with the deleted immunoreceptor tyrosine-based activation motif (K1m).
192 these SH2 domains by tyrosine-phosphorylated immunoreceptor tyrosine-based activation motifs leads to
193 lucan component of yeast is dependent on the immunoreceptor tyrosine-based activation motif-like doma
194 Lyn Src-family kinase with an intracellular immunoreceptor tyrosine-based activation motif-like sequ
195 ation of two tyrosine residues located in an immunoreceptor tyrosine-based activation motif-like sequ
196 high levels on dendritic cells, contains an immunoreceptor tyrosine-based activation motif-like sign
197 Grb2 and Shc adaptors, which associate with immunoreceptor tyrosine based activation motifs, may lin
198 e evident despite a severe impairment of the immunoreceptor tyrosine-based activation motif-mediated
200 nthetic phosphorylated peptides based on the immunoreceptor tyrosine-based activation motif of the be
201 eract with a diphosphopeptide modeled on the immunoreceptor tyrosine-based activation motif of the CD
202 sistent with signaling through the intrinsic immunoreceptor tyrosine-based activation motif of the cy
203 Cells (LAT) and the tyrosine-phosphorylated immunoreceptor tyrosine-based activation motif of the Fc
204 st events involve the phosphorylation of the immunoreceptor tyrosine-based activation motifs of Ig al
205 III, and IV induces cell activation via the immunoreceptor tyrosine-based activation motif on the co
206 FcalphaR and wild-type gamma-chain (wt-ITAM (immunoreceptor tyrosine-based activation motif)) or Fcal
207 showed that both tyrosines of the CD3epsilon immunoreceptor tyrosine-based activation motif partition
208 itogen-activated protein kinase pathway, the immunoreceptor tyrosine-based activation motif pathway,
209 k SH2 domain association with phosphorylated immunoreceptor tyrosine based activation motifs peptide.
210 y similar, but doubly phosphorylated CD3zeta immunoreceptor tyrosine-based activation motif peptide b
211 that SHIP binds in vitro to a phosphorylated immunoreceptor tyrosine-based activation motif, peptide
212 nduced by binding of tyrosine-phosphorylated immunoreceptor tyrosine-based activation motif peptides.
213 orylated or bound to tyrosine-phosphorylated immunoreceptor tyrosine-based activation motif peptides.
214 in vitro by synthetic doubly phosphorylated immunoreceptor tyrosine-based activation motif peptides.
215 nding of TCR-derived tyrosine phosphorylated immunoreceptor tyrosine-based activation motif peptides.
216 nd, thus, are brought into juxtaposition for immunoreceptor tyrosine-based activation motif phosphory
218 receptors in hemostasis, the contribution of immunoreceptor tyrosine-based activation motif receptors
219 3 glycoproteins that belong to the family of immunoreceptor tyrosine-based activation motif receptors
220 ural motifs of R1, including the presence of immunoreceptor tyrosine-based activation motifs, resembl
221 )-chain, which, by virtue of its cytoplasmic immunoreceptor tyrosine-based activation motif, sends ac
222 to summarize recent findings on how platelet immunoreceptor tyrosine-based activation motif signaling
223 ever, have identified new roles for platelet immunoreceptor tyrosine-based activation motif signaling
224 al an important contribution of Grb2 in (hem)immunoreceptor tyrosine-based activation motif signaling
225 at Grb2 is a crucial adapter protein in (hem)immunoreceptor tyrosine-based activation motif signaling
226 In vivo, this selective (hem)immunoreceptor tyrosine-based activation motif signaling
227 that CLP36 acts as a major inhibitor of GPVI immunoreceptor tyrosine-based activation motif signaling
228 veal an inhibitory function of CLP36 in GPVI immunoreceptor tyrosine-based activation motif signaling
229 (BCR), and its cytoplasmic tail contains an immunoreceptor tyrosine-based activation motif that can
230 tory role for the nonconventional beta chain immunoreceptor tyrosine-based activation motif that cont
231 the recruitment of Syk to the phosphorylated immunoreceptor tyrosine-based activation motif tyrosines
232 ore, Ig alpha/Ig beta complexes in which the immunoreceptor tyrosine-based activation motif tyrosines
233 Phosphorylation of the conserved immunoreceptor tyrosine-based activation motif tyrosines
234 sociated with the phosphorylated FcgammaRIIa immunoreceptor tyrosine-based activation motif via the S
236 re portions of the first and second of three immunoreceptor tyrosine-based activation motifs which ar
237 nsduced phosphorylation of its intracellular immunoreceptor tyrosine-based activation motif, which in
238 induces a multitude of positive signals via immunoreceptor tyrosine-based activation motifs, which l
240 o the cell interior through the action of an immunoreceptor tyrosine-based activation motif within th
241 cells, as well as the presence of a putative immunoreceptor tyrosine-based activation motif within th
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。